Skip to search formSkip to main contentSkip to account menu

Trypanosoma brucei gambiense Ab:PrThr:Pt:Ser:Ord

Known as: Trypanosoma brucei gambiense As:PrThr:Moment:Serum:Ordinaal, ???? ????? ??? ??:????:????:??:????, Trypanosoma brucei gambiense Ac:ACnc:Pt:Soro:Ord 
National Institutes of Health

Related topics

Related topics

5 relations
AntibodiesMicrobiology procedureSerumTrypanosoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis
BackgroundThe emphasis placed on the activities of mobile teams in the detection of gambiense human African trypanosomiasis (HAT… 
Highly Cited
2013
Highly Cited
2013
The TgsGP Gene Is Essential for Resistance to Human Serum in Trypanosoma brucei gambiense
Trypanosoma brucei gambiense causes 97% of all cases of African sleeping sickness, a fatal disease of sub-Saharan Africa. Most… 
Highly Cited
2013
Highly Cited
2013
A Single Amino Acid Substitution in the Group 1 Trypanosoma brucei gambiense Haptoglobin-Hemoglobin Receptor Abolishes TLF-1 Binding
Critical to human innate immunity against African trypanosomes is a minor subclass of human high-density lipoproteins, termed… 
Highly Cited
2012
Highly Cited
2012
Supplementary Text S 1 : Model formulation Identifying transmission cycles at the human-animal interface : The role of animal reservoirs in maintaining gambiense Human African Trypanosomiasis
(2013) Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining gambiense… 
2012
2012
Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness
Background Sleeping sickness, or human African trypanosomiasis (HAT), is a protozoan disease that affects rural communities in… 
Highly Cited
2011
Highly Cited
2011
The Human African Trypanosomiasis Control and Surveillance Programme of the World Health Organization 2000–2009: The Way Forward
One century ago human African trypanosomiasis (HAT), also known as sleeping sickness, was believed to curb the development of… 
Review
2010
Review
2010
NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness
Fatal if untreated, human African trypanosomiasis (HAT; sleeping sickness) afflicts an estimated 50,000–70,000 people each year… 
2008
2008
What happens when Trypanosoma brucei leaves Africa.
Highly Cited
2001
Highly Cited
2001
The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda
Highly Cited
1994
Highly Cited
1994
Epidemiological relationships of Trypanosoma brucei stocks from South East Uganda: evidence for different population structures in human infective and non-human infective isolates
SUMMARY This study represents an analysis of trypanosome strains circulating within a confined location over a short period of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)